Mazen Saleh

Senior Policy Director, Healthier Communities

About Mazen

Mazen Saleh oversees the Healthier Communities policy program, a multidisciplinary portfolio spanning substance regulation, behavioral health, and thriving families. He brings nearly two decades of nonprofit leadership across policy, health education, publishing, and business development and strategy, including senior roles at the National League for Nursing and the Association of American Medical Colleges. His work has been featured in national outlets including CNBC, National Review, The Washington Post, The Hill, and USA Today.

He holds a master’s degree in global health and development from University College London and a bachelor’s degree in liberal arts from Georgetown University.

Mazen lives in Washington, D.C. with his Siberian Husky, Beau

areas of expertise

Behavioral Health, Healthier Communities, Substance Regulation, Thriving Families

contact

msaleh@rstreet.org

Media Request

For general and media inquiries and to book our experts, please contact: pr@rstreet.org

Research from Mazen

R Sheets Behavioral Health, Harm Reduction, Healthier Communities, Opioid Harm Reduction

Commentary from Mazen

Analysis Behavioral Health, Federal Government Affairs, Harm Reduction, Healthier Communities, Substance Regulation, Thriving Families

Outreach from Mazen

Testimony Behavioral Health, Harm Reduction, Healthier Communities, Sexual Health, South, State Policy

R Street Testimony in Support of Senate Bill 195, “Pharmacies; pharmacists are authorized to dispense preexposure prophylaxis and postexposure prophylaxis under certain conditions.”

Mazen Saleh March 19, 2025

Testimony Behavioral Health, Harm Reduction, Healthier Communities, Sexual Health, South, State Policy

Testimony in Support of Georgia SB 195, authorizing pharmacists to dispense preexposure prophylaxis and postexposure prophylaxis

Mazen Saleh Feb 24, 2025

Coalition Letters, Congressional Letters, Letters Behavioral Health, Federal Government Affairs, Harm Reduction, Healthier Communities, Opioid Harm Reduction

R Street Joins 125 Organizations in Support of the Bipartisan Reentry Act to Expand Medicaid to Incarcerated Individuals Before Release

Mazen Saleh April 17, 2023

Testimony Behavioral Health, Harm Reduction, Healthier Communities, Northeast, State Policy, Substance Regulation, Tobacco Harm Reduction

More Healthier Communities Policy

Filter listing

Newsletters Healthier Communities, Safer Solutions, Substance Regulation, Tobacco Harm Reduction

Mazen Saleh

About Mazen

Research from Mazen

R Sheet On Coercive Treatment for Drug Use

Overdose Prevention Centers and the Federal “Crack House Statute”

R Street Integrated Harm Reduction Principles and Priorities

A More Integrated Approach to Harm Reduction

Commentary from Mazen

When Harm Reduction Isn’t Enough

TV: Mazen Saleh on the Halt All Lethal Trafficking of Fentanyl Act

Burnout or Breakthrough: An Inflection Point for the Center for Tobacco Products

The Real Smokescreen is Nicotine Disinformation

We know how to save Black Americans from overdoses. Will Congress actually do it?

Clean syringes seem counterintuitive to fentanyl fight. But needle exchange saves lives.

Booker, Colleagues Introduce Bipartisan SEEK HELP Act to Save Lives Amidst Overdose

Trump’s surgeon general urges red states to support needle exchanges

World Health Organization’s Misguided Call for E-Cigarette Flavor Ban

Tillis, Colleagues Reintroduce Bipartisan Legislation to Expand Telehealth Treatment for Opioid Use Disorder

Outreach from Mazen

R Street Testimony in Support of Senate Bill 195, “Pharmacies; pharmacists are authorized to dispense preexposure prophylaxis and postexposure prophylaxis under certain conditions.”

Testimony in Support of Georgia SB 195, authorizing pharmacists to dispense preexposure prophylaxis and postexposure prophylaxis

Coalition Letter in Support of the Reentry Act and the Due Process Continuity of Care Act

R Street Letter Opposing the Combating Illicit Xylazine Act

R Street Institute Signs Coalition Letter Asking Congress To Pass The TEST Act

R Street Institute and 157 Organizations Urge Congress to Vote NO on H.R. 467, the HALT Fentanyl Act

R Street Joins 125 Organizations in Support of the Bipartisan Reentry Act to Expand Medicaid to Incarcerated Individuals Before Release

Testimony in Opposition to Preemption Repeal Concerning Tobacco Control in Rhode Island

Integrated Harm Reduction Statement for the Record for House Judiciary Subcommittee Hearing on the Fentanyl Crisis

R Street Comments for FDA’s Proposed Tobacco Product Standards for Menthol in Cigarettes and Flavored Cigars

Stay in the know. Sign up for R Street’s newsletters today.

More Healthier Communities Policy

Filter listing

Safer Solutions: The FDA authorized flavored vapes. Now what?

R Street Comments on the Proposed FDA/CTP Flavor Guidance

New study finds older Americans left behind by decades of smoking cessation progress

Addressing the Stagnation of Smoking Cessation in Older Adults: Behavioral Barriers, Harm Reduction, and Policy Reform

Why the FDA’s Politically Driven First-Ever Flavored-Vape Approval Almost Gets the Science Right

When Harm Reduction Isn’t Enough

Safer Solutions: Smoking Hits an All-Time Low—But Not for Everyone

New study finds middle-skills training offers path toward filling worker shortages